Healthcare and pharmaceutical

In today's pharmaceutical and healthcare sectors, companies encounter formidable management hurdles, including a diminishing success rate in new drug development and escalating development expenses. To tackle these challenges and enhance overall efficiency, industry players are actively pursuing cross-industry partnerships and leveraging digital technologies. Fujitsu, for instance, harnesses the power of data analysis and AI technology to deliver substantial value, contributing to the transformation of the sector and empowering companies to boost their competitive edge, particularly in areas like disease prevention.

Capabilities

Medical data utilization service

We offer a standardized platform for electronic medical record information, ensuring secure and efficient utilization of medical data stored in the cloud. Collaborating closely with medical institutions and pharmaceutical companies, our aim is to advance the realms of personalized medicine and facilitate innovation in new drug development within the digital health ecosystem.

Corporate health management

We aggregate and analyze employee health data to identify factors affecting health and predict their potential impact on key management indicators. Our goal is to foster a culture of health management, enhance productivity, and create a vibrant and energized work environment.

Digitization of new drug development

Our commitment lies in facilitating the digital transformation of new drug development, with the primary objective of minimizing both development timelines and costs through the effective utilization of data and AI technology. We endeavor to securely harness medical data on a cloud-based platform, thereby streamlining and expediting the drug discovery process.

Strengthening customer contacts and relationships

Harnessing advanced ICT to effectively utilize medical and health data and optimize customer response, we are contributing to the creation of new patient experiences.

Post-marketing surveillance

To ensure the effectiveness and safety of pharmaceuticals, we offer support that simplifies the process of data collection and management, facilitating swift responses. This facilitates seamless information sharing between medical institutions and pharmaceutical companies, ultimately enhancing operational efficiency.

Regional medical network

We can enable secure information sharing between medical institutions in regional medical networks. By consolidating and sharing medical information, we support the safe lives of local residents and contribute to the establishment of a medical care delivery system.

Hospital management transformation

We support optimal hospital management by utilizing cutting-edge ICT and optimizing working hour management and resource management.

Transformation of welfare-related businesses

We are dedicated to facilitating the transformation of welfare and nursing care services, aiming to establish a comprehensive, one-stop welfare system customized for local communities and individuals. Our focus is on promoting efficient business practices and fostering a reform in work styles, all in pursuit of creating a secure and thriving society that promotes the well-being and longevity of its inhabitants.

Insights

[Joint research] Improving quality of life for cancer patients through AI breakthroughs in genomics

Cancer genome medicine, also known as precision cancer medicine, seeks to offer tailored treatment strategies based on the specific genetic mutations present in a patient's cancer tissue. This field offers the potential for personalized medical care, aligning treatment with the unique genomic characteristics of each patient's cancer. It holds the promise of becoming an ideal approach to cancer treatment.

Two men smiling looking at the camera in an orange background

Key focus areas achieving a sustainable world

Customer stories

The inside of a laboratory

Aichi Cancer Center - Supporting quick selection of cancer genomic medicine with AI technology

Using Fujitsu AI technology for information extraction and graph structuring, Aichi Cancer Center Research Institute has developed a system to quickly narrow down candidate drugs for use in targeted cancer genomic therapies. The system significantly reduces the burden on clinicians who previously had to search through vast libraries of medical literature and clinical test results to develop effective therapies.